{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:30:17Z","timestamp":1787027417267,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20810"],"award-info":[{"award-number":["U24A20810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272847"],"award-info":[{"award-number":["82272847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mtbio.2026.103345","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:32:53Z","timestamp":1781458373000},"page":"103345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Edaravone-loaded ROS-responsive nanosystem for targeted ischemic stroke therapy by crossing the gut-brain barrier"],"prefix":"10.1016","volume":"39","author":[{"given":"Wujing","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2433-8842","authenticated-orcid":false,"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20 Suppl 2","key":"10.1016\/j.mtbio.2026.103345_bib1","first-page":"6","article-title":"Global epidemiology of stroke and access to acute ischemic stroke interventions","volume":"97","author":"Saini","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103345_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/17474930231210448","article-title":"Global stroke statistics 2023: availability of reperfusion services around the world","volume":"19","author":"Kim","year":"2024","journal-title":"Int. J. Stroke"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103345_bib3","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1161\/STROKEAHA.123.043131","article-title":"Global, regional, and national economic consequences of stroke","volume":"54","author":"Gerstl","year":"2023","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103345_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"18","key":"10.1016\/j.mtbio.2026.103345_bib5","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.3390\/ijms21186454","article-title":"Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches","volume":"21","author":"Maida","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103345_bib6","first-page":"343","article-title":"Therapeutic options for disabling acute ischemic stroke","volume":"109","author":"Moreno-Gomez","year":"2024","journal-title":"Med. Clin."},{"key":"10.1016\/j.mtbio.2026.103345_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678744","article-title":"Immune cells in the BBB disruption after Acute ischemic stroke: targets for immune therapy?","volume":"12","author":"Qiu","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103345_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1474-4422(22)00519-1","article-title":"Thrombolysis for acute ischaemic stroke: current status and future perspectives","volume":"22","author":"Tsivgoulis","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mtbio.2026.103345_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108541","article-title":"Signaling pathways in brain ischemia: mechanisms and therapeutic implications","volume":"251","author":"Lin","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"21","key":"10.1016\/j.mtbio.2026.103345_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036765","article-title":"Efficacy and safety of intravenous tenecteplase before endovascular thrombectomy for acute ischemic stroke: the multicenter, randomized, BRIDGE-TNK trial protocol","volume":"13","author":"Qiu","year":"2024","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103345_bib11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/neurintsurg-2016-012379","article-title":"Mechanical thrombectomy with the ERIC retrieval device: initial experience","volume":"9","author":"Raoult","year":"2016","journal-title":"J. Neurointerventional Surg."},{"key":"10.1016\/j.mtbio.2026.103345_bib12","article-title":"Advances in treatments for acute ischemic stroke","volume":"389","author":"Sharma","year":"2025","journal-title":"Clin. Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103345_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103345_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jalz.2009.06.003","article-title":"Alzheimer's disease drug development and the problem of the blood-brain barrier","volume":"5","author":"Pardridge","year":"2009","journal-title":"Alzheimer's Dement."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103345_bib15","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s11064-023-03923-x","article-title":"Ischemia reperfusion injury induced blood brain barrier dysfunction and the involved molecular mechanism","volume":"48","author":"Guo","year":"2023","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103345_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","article-title":"Blood-brain barrier: structural components and function under physiologic and pathologic conditions","volume":"1","author":"Persidsky","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103345_bib17","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s00018-019-03287-y","article-title":"Apolipoprotein E-mediated regulation of selenoprotein P transportation via exosomes","volume":"77","author":"Jin","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"28","key":"10.1016\/j.mtbio.2026.103345_bib18","doi-asserted-by":"crossref","first-page":"13737","DOI":"10.1039\/C8NR02971G","article-title":"Hierarchically stimuli-responsive nanovectors for improved tumor penetration and programed tumor therapy","volume":"10","author":"Liu","year":"2018","journal-title":"Nanoscale"},{"issue":"10493","key":"10.1016\/j.mtbio.2026.103345_bib19","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(25)00549-5","volume":"405","author":"Anderson","year":"2025","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103345_bib20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjp.0707130","article-title":"Nanoparticles: pharmacological and toxicological significance","volume":"150","author":"Medina","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103345_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/joccuh\/uiaf002","article-title":"Adverse effects of nanoparticles on humans","volume":"67","author":"Morimoto","year":"2025","journal-title":"J. Occup. Health"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103345_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.femsre.2005.03.004","article-title":"Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy","volume":"29","author":"de Koning","year":"2005","journal-title":"FEMS Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103345_bib23","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1021\/acs.chemrev.0c00644","article-title":"Toward a molecular basis of cellular nucleoside transport in humans","volume":"121","author":"Wright","year":"2020","journal-title":"Chem. Rev."},{"issue":"2\u20133","key":"10.1016\/j.mtbio.2026.103345_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","article-title":"The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29","volume":"34","author":"Young","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.mtbio.2026.103345_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2019.04.031","article-title":"LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases","volume":"303","author":"Guo","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103345_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113955","article-title":"Dual-barrier traversing liposomes with ROS-responsive rigidity tuning for oral ischemic stroke therapy","volume":"385","author":"Zhang","year":"2025","journal-title":"J. Contr. Release"},{"issue":"26","key":"10.1016\/j.mtbio.2026.103345_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402376","article-title":"Blood-brain barrier-penetrating metal-organic framework antioxidant nanozymes for targeted ischemic stroke therapy","volume":"14","author":"Chen","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103345_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/antiox13060706","article-title":"Nanotechnological approaches to enhance the potential of \u03b1-Lipoic acid for application in the clinic","volume":"13","author":"Bellini","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.mtbio.2026.103345_bib29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jconrel.2022.09.060","article-title":"H2S responsive PEGylated poly (lipoic acid) with ciprofloxacin for targeted therapy of Salmonella","volume":"351","author":"Han","year":"2022","journal-title":"J. Contr. Release"},{"issue":"20","key":"10.1016\/j.mtbio.2026.103345_bib30","doi-asserted-by":"crossref","first-page":"19685","DOI":"10.1021\/acsnano.3c02886","article-title":"Phenylboronic acid-modified gold nanoclusters as a nanoantibiotic to treat vancomycin-resistant enterococcus faecalis-caused infections","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103345_bib31","article-title":"Dynamic ROS-responsive hyperbranched polymer-based neuroprotective drug delivery system for pathogenesis-adaptive sequential therapy of cerebral ischemic stroke","volume":"326","author":"Ma","year":"2025","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103345_bib32","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1021\/acsnano.8b01994","article-title":"Simultaneous blood-brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles","volume":"12","author":"Bao","year":"2018","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103345_bib33","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213949","article-title":"Clinical and safety outcomes of edaravone dexborneol in acute ischemic stroke: a multicenter, prospective, cohort Study","volume":"105","author":"Ma","year":"2025","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1016\/j.mtbio.2026.103345_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1242\/jcs.102.3.581","article-title":"Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2","volume":"102","author":"Peterson","year":"1992","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103345_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032568","article-title":"Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model","volume":"7","author":"Wagner","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103345_bib36","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s12035-022-02745-2","article-title":"In vitro oxygen glucose deprivation model of ischemic stroke: a proteomics-driven systems biological perspective","volume":"59","author":"Babu","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103345_bib37","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1080\/17460441.2017.1378176","article-title":"Absorption sites of orally administered drugs in the small intestine","volume":"12","author":"Murakami","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103345_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1248\/bpb.b18-00683","article-title":"Applications of liposomal drug delivery systems to develop neuroprotective agents for the treatment of ischemic stroke","volume":"42","author":"Fukuta","year":"2019","journal-title":"Biol. Pharm. Bull."},{"issue":"42","key":"10.1016\/j.mtbio.2026.103345_bib39","doi-asserted-by":"crossref","first-page":"23143","DOI":"10.1021\/jacs.3c06799","article-title":"Design of an Anti-HMGB1 synthetic antibody for Ischemic\/Reperfusion injury therapy","volume":"145","author":"Koide","year":"2023","journal-title":"J. Am. Chem. Soc."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426005909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426005909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:58:12Z","timestamp":1787025492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426005909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S2590006426005909"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103345","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Edaravone-loaded ROS-responsive nanosystem for targeted ischemic stroke therapy by crossing the gut-brain barrier","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103345"}}